Drug intelligence / Profile preview

Propomax

Development stage
Phase 2
Lead developer
Apis Flora
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Propomax (also known as Clinical Propolis Spray) is a line of propolis-based oral and topical sprays developed by the Brazilian company Apis Flora. The products utilize the EPP-AF standardized propolis extract, which is primarily derived from Brazilian green propolis (*Baccharis dracunculifolia*). This standardized extract is characterized by high concentrations of bioactive compounds, most notably Artepillin C, which confers antimicrobial, anti-inflammatory, antioxidant, and immunomodulatory properties. The Propomax line includes several formulations tailored for specific needs, such as throat irritation relief, voice regeneration, and oral purification, often incorporating additional natural ingredients like honey, ginger, or pomegranate. Clinical studies have shown the spray to be 99% effective against common oral pathogens, including *Staphylococcus aureus* and *Streptococcus mutans*, making it a widely used natural solution for maintaining oral hygiene and treating minor throat discomfort.

Brand names
PropomaxClinical Propolis Spray
Other names
EPP-AF standardized propolis extract
02

Targets

Mpro (3C-like proteinase of SARS-CoV-2)

Beyond the preview

Go deeper on Propomax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propomax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call